Cargando…
Long‐term remission of extramedullary cutaneous relapse of acute myeloid leukaemia (leukaemia cutis) treated with decitabine‐venetoclax
In February 2020, a 74‐year‐old female was diagnosed with myelomonocytic acute myeloid leukaemia with FLT3 mutation and blasts positive for CD33, BCL‐2 and CD68/PGM1. Not responding to a standard Cytarabine–containing regimen plus Midostaurin, the patient achieved a complete remission (CR) of the di...
Autores principales: | Maravalle, Denise, Filosa, Alessandra, Bigazzi, Catia, Collina, Guido, Galieni, Piero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175852/ https://www.ncbi.nlm.nih.gov/pubmed/35846058 http://dx.doi.org/10.1002/jha2.388 |
Ejemplares similares
-
Venetoclax with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia
por: Bouligny, Ian M., et al.
Publicado: (2023) -
A case of leukaemia cutis in a dog with T‐cell chronic lymphocytic leukaemia
por: Bae, Hyeona, et al.
Publicado: (2022) -
Leukaemia cutis for clinicians, a literature review
por: Osmola, Małgorzata, et al.
Publicado: (2021) -
Imaging findings in recurrent extramedullary leukaemias
por: Arrigan, M., et al.
Publicado: (2013) -
Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia
por: Báez-Gutiérrez, Nerea, et al.
Publicado: (2021)